ReviewFrontiers in immunology2026
Immunopathological mechanisms in autoimmune encephalitis: from pathogenesis to targeted therapies.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis (AE) is an antibody-mediated brain disorder involving self-antibody-driven inflammation. Different subtypes present unique clinical and pathological features, influenced by variations in target antigens and underlying pathophysiological processes. Although the precise pathogenesis of each AE subtype remains incompletely understood, recent research has provided valuable insights into their immunopathological mechanisms. This article critically evaluates current discoveries regarding the immunobiology of diverse autoimmune encephalitis categories, elucidating their multifaceted etiological pathways. Furthermore, this review highlights the potential of targeted therapeutic interventions, and personalized treatment strategies, thereby facilitating the translation of mechanism discoveries into precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.